Medix Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	951	-	-	-	-
Depreciation & Amortization	45	-	-	-	-
Other Operating Activities	-376	-	-	-	-
Change in Accounts Receivable	66	-	-	-	-
Change in Accounts Payable	-127	-	-	-	-
Change in Other Net Operating Assets	-60	-	-	-	-
Operating Cash Flow	499	-	-	-	-
Capital Expenditures	-14	-	-	-	-
Sale (Purchase) of Intangibles	-3	-	-	-	-
Other Investing Activities	426	-	-	-	-
Investing Cash Flow	414	-	-	-	-
Long-Term Debt Repaid	-229	-	-	-	-
Net Debt Issued (Repaid)	-229	-	-	-	-
Issuance of Common Stock	368	-	-	-	-
Common Dividends Paid	-60	-	-	-	-
Other Financing Activities	-3	-	-	-	-
Financing Cash Flow	76	-	-	-	-
Miscellaneous Cash Flow Adjustments	1	-	-	-	-
Net Cash Flow	990	-	-	-	-
Free Cash Flow	485	-	-	-	-
Free Cash Flow Margin	11.66%	-	-	-	-
Free Cash Flow Per Share	62.04	-	-	-	-
Cash Interest Paid	2	-	-	-	-
Cash Income Tax Paid	375	-	-	-	-
Levered Free Cash Flow	433	-	-	-	-
Unlevered Free Cash Flow	434.25	-	-	-	-
Change in Working Capital	-121	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.